Farah Ashrafzadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Farah Ashrafzadeh has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Mehran Beiraghi Toosi
Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
4 shared publications - Narges Hashemi
Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
4 shared publications - Javad Akhondian
Mashhad University of Medical Sciences
3 shared publications - Shima Imannezhad
Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3 shared publications - Ehsan Ghayoor Karimiani
Department of Medical Genetics, Next Generation Genetic Polyclinic, Mashhad, Iran
2 shared publications - Mahla Esmaeilzadeh
Sinus and Surgical Endoscopic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Neurosurgical Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publications
Latest Publications
- 11 November 2026
- Published by Wiley in Journal of Applied Research in Intellectual Disabilities
- Vol. 39 (6)
Development and Psychometric Properties of the Caring Motivation Scale ( CMS ) in Mothers of Children With Intellectual Disability: A Mixed‐Method Study
Background: No validated scale exists to measure caregiving motivation in mothers of children with intellectual disability. This study developed the Caring Motivation Scale (CMS). Methods: An exploratory mixed‐methods design was used. Twenty‐six mothers were interviewed using Mayring's deductive content analysis based on SDT. Waltz's framework yielded 152 items. Face validity was assessed with 10 mothers, and content validity with 15 experts using CVR and CVI. Content validation reduced the scale to 68 items, and item analysis to 61. Three hundred twenty‐nine mothers completed the scale. CFA tested a five‐factor model. Reliability was assessed using Cronbach's α , ICC and SEM. Results: Five categories emerged: intrinsic, identified extrinsic, introjected extrinsic, external extrinsic and amotivation. CFA confirmed the five‐factor model. The CMS showed excellent reliability ( α = 0.96; ICC = 0.96; SEM = 1.69). Conclusion: The CMS is a valid and reliable measure of caregiving motivation in mothers of children with intellectual disabilities.
- 11 November 2026
- Published by Wiley in Journal of Applied Research in Intellectual Disabilities
- Vol. 39 (6)
Development and Psychometric Properties of the Caring Motivation Scale ( CMS ) in Mothers of Children With Intellectual Disability: A Mixed‐Method Study
Background: No validated scale exists to measure caregiving motivation in mothers of children with intellectual disability. This study developed the Caring Motivation Scale (CMS). Methods: An exploratory mixed‐methods design was used. Twenty‐six mothers were interviewed using Mayring's deductive content analysis based on SDT. Waltz's framework yielded 152 items. Face validity was assessed with 10 mothers, and content validity with 15 experts using CVR and CVI. Content validation reduced the scale to 68 items, and item analysis to 61. Three hundred twenty‐nine mothers completed the scale. CFA tested a five‐factor model. Reliability was assessed using Cronbach's α , ICC and SEM. Results: Five categories emerged: intrinsic, identified extrinsic, introjected extrinsic, external extrinsic and amotivation. CFA confirmed the five‐factor model. The CMS showed excellent reliability ( α = 0.96; ICC = 0.96; SEM = 1.69). Conclusion: The CMS is a valid and reliable measure of caregiving motivation in mothers of children with intellectual disabilities.
- Open Access
- 28 February 2026
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 31 (1) , 3-10
Unraveling PEX6: insights into very-long-chain fatty acid levels and peroxisome biogenesis disorders in pediatric populations
Peroxisome biogenesis disorders (PBDs) are a genetically heterogeneous group of metabolic diseases caused by impaired peroxisome assembly and function. PBDs exhibit striking clinical variability, ranging from lethal neonatal forms (e.g., Zellweger spectrum disorders) to milder childhood-onset presentations such as rhizomelic chondrodysplasia punctata. While elevated levels of very-long-chain fatty acids (VLCFAs) remain a key diagnostic feature, the existence of unusual cases with normal plasma VLCFA levels highlight the limitations of relying solely on this biochemical marker for diagnosis. Genetic variations in PEX6, an important peroxisome biogenesis factor, contribute significantly to this phenotypic diversity, with missense variants often associated with less severe disease compared to truncating mutations. Recent studies further implicate dysregulated pexophagy—a targeted autophagic degradation of peroxisomes—in the underlying disease mechanisms. This review underscores the necessity for a multifaceted diagnostic approach that, thorough clinical assessment, detailed biochemical evaluation, and advanced molecular genetic testing, seeks to improve diagnostic accuracy and patient care, particularly in pediatric populations. Advancements in identifying novel biomarkers and targeted therapies offer promise for tailored interventions, underscoring the importance of precision medicine in optimizing outcomes for pediatric PBD patients.
- 28 February 2026
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 31 (1) , 3-10
Open AccessUnraveling PEX6: insights into very-long-chain fatty acid levels and peroxisome biogenesis disorders in pediatric populations
Peroxisome biogenesis disorders (PBDs) are a genetically heterogeneous group of metabolic diseases caused by impaired peroxisome assembly and function. PBDs exhibit striking clinical variability, ranging from lethal neonatal forms (e.g., Zellweger spectrum disorders) to milder childhood-onset presentations such as rhizomelic chondrodysplasia punctata. While elevated levels of very-long-chain fatty acids (VLCFAs) remain a key diagnostic feature, the existence of unusual cases with normal plasma VLCFA levels highlight the limitations of relying solely on this biochemical marker for diagnosis. Genetic variations in PEX6, an important peroxisome biogenesis factor, contribute significantly to this phenotypic diversity, with missense variants often associated with less severe disease compared to truncating mutations. Recent studies further implicate dysregulated pexophagy—a targeted autophagic degradation of peroxisomes—in the underlying disease mechanisms. This review underscores the necessity for a multifaceted diagnostic approach that, thorough clinical assessment, detailed biochemical evaluation, and advanced molecular genetic testing, seeks to improve diagnostic accuracy and patient care, particularly in pediatric populations. Advancements in identifying novel biomarkers and targeted therapies offer promise for tailored interventions, underscoring the importance of precision medicine in optimizing outcomes for pediatric PBD patients.
- 22 July 2022
- Published by Taylor & Francis in Journal of Binocular Vision and Ocular Motility
- Vol. 72 (4) , 199-204
Recurrent Painful Ophthalmoplegic Neuropathy with Unilateral Oculomotor and Trochlear Nerve Palsy in an 8-year-old Girl
Recurrent painful ophthalmoplegic neuropathy (RPON) is a rare disorder with a unilateral headache accompanied by ipsilateral episodes of painful ocular cranial nerve neuropathy, which typically occurs in childhood. We report an 8-year-old female with four episodes of RPON involving unilateral third and fourth cranial nerves. Right eye exotropia and complete ptosis were detected on examination. Brain MRI images revealed right third nerve enhancement where it exits from the brainstem. She completely recovered after 5 weeks with the administration of prednisolone and indomethacin. Due to the rarity of this condition in children, recurrent painful ophthalmoplegic neuropathy should be considered as a differential diagnosis of unilateral or bilateral painful ophthalmoplegia, particularly with a history of migrainous headache. Since it is a treatable entity, and repeated attacks may lead to permanent sequela, early intervention is crucial.
- 22 July 2022
- Published by Taylor & Francis in Journal of Binocular Vision and Ocular Motility
- Vol. 72 (4) , 199-204
Recurrent Painful Ophthalmoplegic Neuropathy with Unilateral Oculomotor and Trochlear Nerve Palsy in an 8-year-old Girl
Recurrent painful ophthalmoplegic neuropathy (RPON) is a rare disorder with a unilateral headache accompanied by ipsilateral episodes of painful ocular cranial nerve neuropathy, which typically occurs in childhood. We report an 8-year-old female with four episodes of RPON involving unilateral third and fourth cranial nerves. Right eye exotropia and complete ptosis were detected on examination. Brain MRI images revealed right third nerve enhancement where it exits from the brainstem. She completely recovered after 5 weeks with the administration of prednisolone and indomethacin. Due to the rarity of this condition in children, recurrent painful ophthalmoplegic neuropathy should be considered as a differential diagnosis of unilateral or bilateral painful ophthalmoplegia, particularly with a history of migrainous headache. Since it is a treatable entity, and repeated attacks may lead to permanent sequela, early intervention is crucial.
- Open Access
- 7 June 2022
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (9) , 2652-2665
TTC5 syndrome: Clinical and molecular spectrum of a severe and recognizable condition
Biallelic mutations in the TTC5 gene have been associated with autosomal recessive intellectual disability (ARID) and subsequently with an ID syndrome including severe speech impairment, cerebral atrophy, and hypotonia as clinical cornerstones. A TTC5 role in IDs has been proposed based on the physical interaction of TTC5 with p300, and possibly reducing p300 co‐activator complex activity, similarly to what was observed in Menke‐Hennekam 1 and 2 patients (MKHK1 and 2) carrying, respectively, mutations in exon 30 and 31 of CREBBP and EP300, which code for the TTC5‐binding region. Recently, TTC5‐related brain malformation has been linked to tubulinopathies due to the function of TTC5 in tubulins' dynamics. We reported seven new patients with novel or recurrent TTC5 variants. The deep characterization of the molecular and phenotypic spectrum confirmed TTC5‐related disorder as a recognizable, very severe neurodevelopmental syndrome. In addition, other relevant clinical aspects, including a severe pre‐ and postnatal growth retardation, cryptorchidism, and epilepsy, have emerged from the reversal phenotype approach and the review of already published TTC5 cases. Microcephaly and facial dysmorphism resulted in being less variable than that documented before. The TTC5 clinical features have been compared with MKHK1 published cases in the hypothesis that clinical overlap in some characteristics of the two conditions was related to the common p300 molecular pathway.
- 7 June 2022
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (9) , 2652-2665
Open AccessTTC5 syndrome: Clinical and molecular spectrum of a severe and recognizable condition
Biallelic mutations in the TTC5 gene have been associated with autosomal recessive intellectual disability (ARID) and subsequently with an ID syndrome including severe speech impairment, cerebral atrophy, and hypotonia as clinical cornerstones. A TTC5 role in IDs has been proposed based on the physical interaction of TTC5 with p300, and possibly reducing p300 co‐activator complex activity, similarly to what was observed in Menke‐Hennekam 1 and 2 patients (MKHK1 and 2) carrying, respectively, mutations in exon 30 and 31 of CREBBP and EP300, which code for the TTC5‐binding region. Recently, TTC5‐related brain malformation has been linked to tubulinopathies due to the function of TTC5 in tubulins' dynamics. We reported seven new patients with novel or recurrent TTC5 variants. The deep characterization of the molecular and phenotypic spectrum confirmed TTC5‐related disorder as a recognizable, very severe neurodevelopmental syndrome. In addition, other relevant clinical aspects, including a severe pre‐ and postnatal growth retardation, cryptorchidism, and epilepsy, have emerged from the reversal phenotype approach and the review of already published TTC5 cases. Microcephaly and facial dysmorphism resulted in being less variable than that documented before. The TTC5 clinical features have been compared with MKHK1 published cases in the hypothesis that clinical overlap in some characteristics of the two conditions was related to the common p300 molecular pathway.
- Open Access
- 28 March 2022
- Published by Knowledge E DMCC in ACTA MEDICA IRANICA
CEDNIK Syndrome, a Rare Neuro-Cutaneous Disorder in an Iranian Patient: Case Report and Review of Specific Neuro-Ichthyotic Syndromes
Cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma (CEDNIK) syndrome is an autosomal recessive neuro-cutaneous disorder characterized by a collection of clinical manifestations, including microcephaly, cerebral dysgenesis, palmoplantar keratoderma, facial dysmorphism, and ichthyosis. The etiology of this condition has been proved to be a homozygous mutation in the SNAP29 gene, which has an essential role in dermatological and neurological manifestations of this syndrome. In this report, we present the first documented Iranian patient with CEDNIK syndrome. So far, only 14 cases of this condition have been reported globally.
- 28 March 2022
- Published by Knowledge E DMCC in ACTA MEDICA IRANICA
Open AccessCEDNIK Syndrome, a Rare Neuro-Cutaneous Disorder in an Iranian Patient: Case Report and Review of Specific Neuro-Ichthyotic Syndromes
Cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma (CEDNIK) syndrome is an autosomal recessive neuro-cutaneous disorder characterized by a collection of clinical manifestations, including microcephaly, cerebral dysgenesis, palmoplantar keratoderma, facial dysmorphism, and ichthyosis. The etiology of this condition has been proved to be a homozygous mutation in the SNAP29 gene, which has an essential role in dermatological and neurological manifestations of this syndrome. In this report, we present the first documented Iranian patient with CEDNIK syndrome. So far, only 14 cases of this condition have been reported globally.
- Open Access
- 1 April 2021
- Published by Negah Scientific Publisher in Caspian Journal of Neurological Sciences
- Vol. 7 (2) , 60-73
Classifying the Epilepsy Based on the Phase Space Sorted With the Radial Poincaré Sections in Electroencephalography
Background: Epilepsy is a brain disorder that changes the basin geometry of the oscillation of trajectories in the phase space. Nevertheless, recent studies on epilepsy often used the statistical characteristics of this space to diagnose epileptic seizures. Objectives: We evaluated changes caused by the seizures on the mentioned basin by focusing ...
- 1 April 2021
- Published by Negah Scientific Publisher in Caspian Journal of Neurological Sciences
- Vol. 7 (2) , 60-73
Open AccessClassifying the Epilepsy Based on the Phase Space Sorted With the Radial Poincaré Sections in Electroencephalography
Background: Epilepsy is a brain disorder that changes the basin geometry of the oscillation of trajectories in the phase space. Nevertheless, recent studies on epilepsy often used the statistical characteristics of this space to diagnose epileptic seizures. Objectives: We evaluated changes caused by the seizures on the mentioned basin by focusing ...